The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington’s disease chromosomes. Cell. 1993;72:971–83.
Ghosh R, Tabrizi SJ. Huntington disease. Handb Clin Neurol. 2018;147:255–78.
Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020. https://doi.org/10.1038/s41582-020-0389-4.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:15005.
Kerschbamer E, Biagioli M. Huntington’s disease as neurodevelopmental disorder: altered chromatin regulation, coding, and non-coding RNA transcription. Front Neurosci. 2016;9(JAN):174074.
Wiatr K, Szlachcic WJ, Trzeciak M, Figlerowicz M, Figiel M. Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells. Mol Neurobiol. 2017;:1–21.
Conforti P, Besusso D, Bocchi VD, Faedo A, Cesana E, Rossetti G, et al. Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes. Proc Natl Acad Sci. 2018;115:E762–71.
CAS PubMed PubMed Central Google Scholar
Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, et al. Huntington’s disease alters human neurodevelopment. Science. 2020;369:787–93.
CAS PubMed PubMed Central Google Scholar
The HD iPSC Consortium. Developmental alterations in huntington’s disease neural cells and Pharmacological rescue in cells and mice. Nat Neurosci. 2017;20:648–60.
Siebzehnrübl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, et al. Early postnatal behavioral, cellular, and molecular changes in models of huntington disease are reversible by HDAC Inhibition. Proc Natl Acad Sci U S A. 2018;115:E8765–74.
PubMed PubMed Central Google Scholar
Li L, Liu H, Dong P, Li D, Legant WR, Grimm JB, et al. Real-time imaging of Huntingtin aggregates diverting target search and gene transcription. Elife. 2016;5:AUGUST.
DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Sci (80-). 1997;277:1990–3.
Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S. The pathobiology of perturbed mutant Huntingtin protein-protein interactions in huntington’s disease. J Neurochem. 2019;151:507–19.
Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S. Loss of normal Huntingtin function: new developments in huntington’s disease research. Trends Neurosci. 2001;24:182–8.
Mehler MF, Petronglo JR, Arteaga-Bracho EE, Gulinello ME, Winchester ML, Pichamoorthy N, et al. Loss-of-huntingtin in medial and lateral ganglionic lineages differentially disrupts regional interneuron and projection neuron subtypes and promotes huntington’s disease-associated behavioral, cellular and pathological hallmarks. J Neurosci. 2019;39:2443–18.
Saudou F, Humbert S. The biology of Huntingtin. Neuron. 2016;89:910–26.
Dragatsis I, Levine MS, Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet. 2000;26:300–6.
Dietrich P, Johnson IM, Alli S, Dragatsis I. Elimination of Huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis. PLOS Genet. 2017;13:e1006846.
PubMed PubMed Central Google Scholar
Nasir J, Floresco SB, O’Kusky JR, Diewert VM, Richman JM, Zeisler J, et al. Targeted disruption of the huntington’s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995;81:811–23.
Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, et al. Inactivation of the mouse huntington’s disease gene homolog Hdh. Science. 1995;269:407–10.
White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al. Huntingtin is required for neurogenesis and is not impaired by the huntington’s disease CAG expansion. Nat Genet. 1997;17:404–10.
Arteaga-Bracho EE, Gulinello M, Winchester ML, Pichamoorthy N, Petronglo JR, Zambrano AD, et al. Postnatal and adult consequences of loss of Huntingtin during development: implications for huntington’s disease. Neurobiol Dis. 2016;96:144–55.
CAS PubMed PubMed Central Google Scholar
Auerbach W, Hurlbert MS, Hilditch-Maguire P, Wadghiri YZ, Wheeler VC, Cohen SI, et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of Huntingtin. Hum Mol Genet. 2001;10:2515–23.
Van Raamsdonk JM, Al-Shekaili HH, Wagner L, Bredy TW, Chan L, Pearson J, et al. Huntingtin decreases susceptibility to a spontaneous seizure disorder in FVN/B mice. Aging Dis. 2023;14:2249–66.
PubMed PubMed Central Google Scholar
Molero AE, Arteaga-Bracho EE, Chen CH, Gulinello M, Winchester ML, Pichamoorthy N, et al. Selective expression of mutant Huntingtin during development recapitulates characteristic features of huntington’s disease. Proc Natl Acad Sci U S A. 2016;113:5736–41.
CAS PubMed PubMed Central Google Scholar
Moumné L, Betuing S, Caboche J. Multiple aspects of gene dysregulation in huntington’s disease. Front Neurol. 2013;4:127.
PubMed PubMed Central Google Scholar
Malla B, Guo X, Senger G, Chasapopoulou Z, Yildirim F. A systematic review of transcriptional dysregulation in huntington’s disease studied by RNA sequencing. Front Genet. 2021;12:1898.
Seredenina T, Luthi-Carter R. What have we learned from gene expression profiles in huntington’s disease? Neurobiol Dis. 2012;45:83–98.
Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human huntington’s disease brain. Hum Mol Genet. 2006;15:965–77.
Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of huntington’s disease. Hum Mol Genet. 2000;9:1259–71.
Martí E, Pantano L, Bañez-Coronel M, Llorens F, Miñones-Moyano E, Porta S, et al. A myriad of MiRNA variants in control and huntington’s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010;38:7219–35.
PubMed PubMed Central Google Scholar
Dabrowska M, Ciolak A, Kozlowska E, Fiszer A, Olejniczak M. Generation of new isogenic models of huntington’s disease using CRISPR-Cas9 technology. Int J Mol Sci. 2020;21:1854.
CAS PubMed PubMed Central Google Scholar
Joachimiak P, Ciesiołka A, Kozłowska E, Świtoński PM, Figura G, Ciołak A, et al. Allele-specific quantitation of ATXN3 and HTT transcripts in PolyQ disease models. BMC Biol. 2023;21:1–16.
Ciesiolka A, Stroynowska-Czerwinska A, Joachimiak P, Ciolak A, Kozlowska E, Michalak M, et al. Artificial MiRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation Inhibition of mutant transcripts. Cell Mol Life Sci. 2021;78:1577–96.
Fjodorova M, Li M. Robust induction of DARPP32-Expressing GABAergic striatal neurons from human pluripotent stem cells. Methods Mol Biol. 2018;1780:585–605.
Harding RJ, Loppnau P, Ackloo S, Lemak A, Hutchinson A, Hunt B, et al. Design and characterization of mutant and wildtype Huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems. J Biol Chem. 2019;294:6986–7001.
CAS PubMed PubMed Central Google Scholar
Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31:8–22.
Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, et al. RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS ONE. 2015;10:e0143563.
PubMed PubMed Central Google Scholar
Pan Y, Zhu Y, Yang W, Tycksen E, Liu S, Palucki J, et al. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. J Biol Chem. 2018;293:11850–66.
CAS PubMed PubMed Central Google Scholar
Jen WP, Chen HM, Lin YS, Chern Y, Lee YC. Twist1 plays an Anti-apoptotic role in mutant Huntingtin expression striatal progenitor cells. Mol Neurobiol. 2020;57:1688–703.
Comments (0)